Ganub, Agustina O.
HRN: 02-51-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/25/2024
06/01/2024
IV
2.25g
Q6H
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes